Showing 21-30 of 824 results for "".
Revealed: The Two Hottest New Skin Cancer Ingredients
https://practicaldermatology.com/conferences/scale-2023/revealed-the-two-hottest-new-skin-cancer-ingredients/20202/Todd Schlesinger, MD, discusses the growing role of exosomes and cannabidiol (CBD) in dermatology.Implementing and Growing PDT
https://practicaldermatology.com/series/pdt-in-practice/implementing-and-growing-pdt/29783/Dr. Todd Schlesinger described how he implemented photodynamic therapy in his practice and the strategies he utilized to increase patient access to it.The Expanding Role for PD-1 Inhibitors for NMSCs
https://practicaldermatology.com/topics/skin-cancer-photoprotection/the-expanding-role-for-pd-1-inhibitors-for-nmscs/19937/The pool of potential patients that could be treated with PD-1 inhibitors is growing. Todd Schlesinger, MD discusses how these drugs may be used to treat a greater number of patients with NMSCs and addresses side effects and their management.Managing Advanced Skin Cancers
https://practicaldermatology.com/conferences/aad-2021/managing-advanced-skin-cancers/19920/Treatment of advanced NMSC can be a challenge, but therapeutic options continue to expand. Todd Schlesinger, MD discusses real-world use of hedgehog inhibitors—including modified regimens and adjuvant use—and PD-1 inhibitors for advanced disease.The Role of Topical Steroids in AD
https://practicaldermatology.com/programs/dermatology-hub-neuroimmune-network/derm-hub/37138/Practical Dermatology Editorial Board member Todd Schlesinger, MD, a board-certified dermatologist and Mohs surgeon with Epiphany Dermatology in Charleston, South Carolina, discusses the role of topical steroids in treating atopic dermatitis.Science of Skincare Summit 2024:The Latest in Exosomes
https://practicaldermatology.com/conferences/science-skincare-summit-2024/science-of-skincare-summit-2024-the-latest-in-exosomes/29450/Practical Dermatology talks with Todd Schlesinger, MD, a dermatologist and Mohs surgeon, and a member of the Editorial Board, about the latest updates in exosomes and what to expect next. This video was recorded at the Science of Skincare Summit in Austin.Diagnostic Approach for Prurigo Nodularis
https://practicaldermatology.com/programs/dermatology-hub-neuroimmune-network/diagnostic-approach-for-prurigo-nodularis/37137/Practical Dermatology Editorial Board member Todd Schlesinger, MD, a board-certified dermatologist and Mohs surgeon with Epiphany Dermatology in Charleston, South Carolina, describes his diagnostic algorithm for prurigo nodularis.The Activation of Itch
https://practicaldermatology.com/programs/dermatology-hub-neuroimmune-network/derm-hub/37141/Practical Dermatology Editorial Board member Todd Schlesinger, MD, a board-certified dermatologist and Mohs surgeon with Epiphany Dermatology in Charleston, South Carolina, discusses the mechanism of itch.Skin Cancer Prevention–Present and Future
https://practicaldermatology.com/programs/practical-dermatology/skin-cancer-prevention-present-and-future/18193/A panel discussion led by Neal Bhatia, MD, reveals the efforts – large and small – being made by dermatologists Laura Ferris, MD, Vishal Patel, MD, and Todd Schlesinger, MD, to combat skin cancer in their clinics and in their communities.Unmet Needs in Atopic Dermatitis
https://practicaldermatology.com/series/dermatology-hub-neuroimmune-network/derm-hub/37140/Practical Dermatology Editorial Board member Todd Schlesinger, MD, a board-certified dermatologist and Mohs surgeon with Epiphany Dermatology in Charleston, South Carolina, talks about what he feels are the greatest unmet needs in atopic dermatitis.